• Latest Posts

Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures

Investment Is Pouring Into Neuromodulation Treatments

Interview 2 Sep 2020

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

Women’s Health Gains Traction as Bayer Pays €736M for UK Firm

UK Startup Bags €3M to Develop Psychedelic Medicines for Mental Health

Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B


Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS

Spanish Neurology Biotech Launches with €7.6M Series A

Phase III Failure Sinks Drug for Rare Neurological Disorder

AskBio Takes Over French Gene Therapy Company to Treat Alzheimer’s and Huntington’s

Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia

Two European Alzheimer’s Disease Treatments Show Promise in Phase II